Lipid profiling of FPLC-separated lipoprotein fractions by electrospray ionization tandem mass spectrometry.
about
Recent advances in targeting the autotaxin-lysophosphatidate-lipid phosphate phosphatase axis in vivoDysfunctional High-Density Lipoprotein: An Innovative Target for Proteomics and LipidomicsHigh density lipoproteins: Measurement techniques and potential biomarkers of cardiovascular riskMechanisms and genetic determinants regulating sterol absorption, circulating LDL levels, and sterol elimination: implications for classification and disease riskOn the future of mass-spectrometry-based lipidomicsThe adipokine/ceramide axis: key aspects of insulin sensitizationTop-down lipidomics reveals ether lipid deficiency in blood plasma of hypertensive patientsCeramide as a mediator of non-alcoholic Fatty liver disease and associated atherosclerosisMetabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological settingLipid alterations in experimental murine colitis: role of ceramide and imipramine for matrix metalloproteinase-1 expression.Metabolomic Identification in Cerebrospinal Fluid of the Effects of High Dietary Cholesterol in a Rabbit Model of Alzheimer's DiseaseVLDL hydrolysis by hepatic lipase regulates PPARĪ“ transcriptional responsesComposition and lipid spatial distribution of HDL particles in subjects with low and high HDL-cholesterol.Blood sphingolipidomics in healthy humans: impact of sample collection methodology.Increased lipid peroxidation in LDL from type-2 diabetic patients.Lysophosphatidic acid in atherosclerotic diseasesAlterations of plasma lysophosphatidylcholine species in obesity and weight loss.Targeted Induction of Ceramide Degradation Leads to Improved Systemic Metabolism and Reduced Hepatic Steatosis.Biochemical and morphological properties of hepatitis C virus particles and determination of their lipidome.Characterization of acid sphingomyelinase activity in human cerebrospinal fluidA simple method to identify ether lipids in spermatozoa samples by MALDI-TOF mass spectrometry.Surfactant lipidomics in healthy children and childhood interstitial lung diseasePlasma lipidomic profiling of treated HIV-positive individuals and the implications for cardiovascular risk prediction.Mass spectrometry based lipidomics: an overview of technological platformsLipidomic changes of LDL in overweight and moderately hypercholesterolemic subjects taking phytosterol- and omega-3-supplemented milk.Oral bioavailability of the ether lipid plasmalogen precursor, PPI-1011, in the rabbit: a new therapeutic strategy for Alzheimer's disease.ApoB-100-containing lipoproteins are major carriers of 3-iodothyronamine in circulation.Improved insulin sensitivity after exercise training is linked to reduced plasma C14:0 ceramide in obesity and type 2 diabetes.Mechanistic insights revealed by lipid profiling in monogenic insulin resistance syndromes.Molecular mechanisms of vascular effects of High-density lipoprotein: alterations in cardiovascular disease.Microsomal Triglyceride Transfer Protein Transfers and Determines Plasma Concentrations of Ceramide and Sphingomyelin but Not Glycosylceramide.A lipidomic analysis approach to evaluate the response to cholesterol-lowering food intakeThe value of grip test, lysophosphatidlycholines, glycerophosphocholine, ornithine, glucuronic acid decrement in assessment of nutritional and metabolic characteristics in hepatitis B cirrhosis.Ceramides contained in LDL are elevated in type 2 diabetes and promote inflammation and skeletal muscle insulin resistance.Plasma ceramides target skeletal muscle in type 2 diabetes.Non-acidic activation of pain-related Acid-Sensing Ion Channel 3 by lipidsRegulation of plasma ceramide levels with fatty acid oversupply: evidence that the liver detects and secretes de novo synthesised ceramide.Identification of candidate diagnostic biomarkers for adolescent idiopathic scoliosis using UPLC/QTOF-MS analysis: a first report of lipid metabolism profiles.A comparison of five lipid extraction solvent systems for lipidomic studies of human LDLLipidomics of familial longevity
P2860
Q26741062-2C359724-37D2-4A17-881A-CC18232EBF35Q26774903-61E0F7B0-674C-4A25-B349-FE626E80A401Q26775420-263447A6-A0B0-445E-B692-999D235CB7CFQ27003094-3F2DEF22-0C1D-4317-8C05-25689DE4970FQ27012927-0D0376A2-7AA6-4745-BF3C-72A408C8F090Q27025041-668C69AD-05AD-46DF-991F-93721729EA34Q28475747-014925CE-EA50-43B1-83CE-5B01C03FBCE4Q28547365-D8F973EE-CD1C-4B7D-B89B-2E5D14625970Q28748492-2CC0A2D8-2D64-4C66-8FD0-3A188496EE09Q33507287-1F91BE4D-DAC2-4A17-863A-9AEEE3046452Q33631144-FC2A4580-5752-4E0B-835E-E9C5E88F955FQ33959265-E280E58E-7BFE-4769-AD0B-F7D6B4313D17Q33993200-CCEFCA09-22E7-40E2-882B-67AEBA9CDB5BQ34116310-0ED1BD15-34FC-4DAF-9D61-F175983910DBQ34152357-9831BE30-5EB1-4E36-B3AE-590B8845B48FQ34273486-9F0F8E09-18EC-4796-AABF-AF9673CE6A4CQ34395775-8E107F87-0513-4E99-9502-BA281E53CF4BQ34485836-F9C5C7A5-8718-4519-9858-A3D8CF74841AQ34509568-8A487D7D-7F2E-4209-A639-F194C1472FBBQ34712835-06E69ECC-48B0-4241-88F0-60FCD62D24C5Q34787218-F1345CBC-64B5-4450-B761-FDBAB72D1885Q35098582-C12293E5-7557-4A96-9809-F23D61659293Q35148082-B8A1312C-E8A5-413F-B4FE-801BE792F058Q35193597-21B652EE-5DAB-4657-B998-A9FA433BB4CFQ35536385-0AA0BF54-B359-48B6-80B3-D30532F2F8C9Q35677425-91A1B057-D6AE-4F0A-95DD-61B4803519FEQ35693962-4A17D981-67A3-4BB0-96A6-EF8E1F03420CQ35788303-9BA83F8B-B1A2-445A-BED0-C7003D9514E6Q35950880-5218B852-D734-4DE7-A8B6-879BC575D816Q36037988-5A63DCF8-BC3C-483F-B178-AC2D52B30931Q36283494-E6BD049B-7DE6-4CEC-B6B2-863908D1D1AAQ36301541-023DEC3C-CC6B-4522-B2B5-93B782B26209Q36338103-80E92C78-0AF4-44CE-A6AE-ACEDE9CF3052Q36560514-D4E6238B-A464-42B8-A5F7-C5E7A90523D4Q36560633-4494C7DE-5B77-46DF-90A0-A58AF04CD2EBQ36584352-A2DA48BD-311D-491A-8EEC-E4E619D1CA89Q36623114-FC163C55-DF43-4425-BBE6-BE05A845D135Q36633427-16AC3591-9E8B-44C4-9171-A22D3734531FQ36920562-55CF066A-A49C-44A4-8309-E6AF8C55E11CQ37005030-EBFE6D98-4509-4244-B78B-7D85D860374E
P2860
Lipid profiling of FPLC-separated lipoprotein fractions by electrospray ionization tandem mass spectrometry.
description
2008 nĆ® lÅ«n-bĆ»n
@nan
2008幓ć®č«ę
@ja
2008幓å¦ęÆęē«
@wuu
2008幓å¦ęÆęē«
@zh
2008幓å¦ęÆęē«
@zh-cn
2008幓å¦ęÆęē«
@zh-hans
2008幓å¦ęÆęē«
@zh-my
2008幓å¦ęÆęē«
@zh-sg
2008幓åøč”ęē«
@yue
2008幓åøč”ęē«
@zh-hant
name
Lipid profiling of FPLC-separa ...... tion tandem mass spectrometry.
@en
Lipid profiling of FPLC-separa ...... tion tandem mass spectrometry.
@nl
type
label
Lipid profiling of FPLC-separa ...... tion tandem mass spectrometry.
@en
Lipid profiling of FPLC-separa ...... tion tandem mass spectrometry.
@nl
prefLabel
Lipid profiling of FPLC-separa ...... tion tandem mass spectrometry.
@en
Lipid profiling of FPLC-separa ...... tion tandem mass spectrometry.
@nl
P2093
P2860
P1476
Lipid profiling of FPLC-separa ...... tion tandem mass spectrometry.
@en
P2093
Alfred Boettcher
Gerd Schmitz
Katharina Leidl
Philipp Wiesner
P2860
P304
P356
10.1194/JLR.D800028-JLR200
P577
2008-10-01T00:00:00Z